2024
Epidemiology and risk factors for hyperkalaemia in heart failure
Grobbee D, Filippatos G, Desai N, Coats A, Pinto F, Rosano G, Cleland J, Kammerer J, de Arellano A. Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure 2024, 11: 1821-1840. PMID: 38439165, PMCID: PMC11287317, DOI: 10.1002/ehf2.14661.Peer-Reviewed Original ResearchHeart failureObservational studyRisk factorsRenin-angiotensin-aldosterone system inhibitorsSevere renal impairmentElevated serum potassiumImpaired renal functionRisk of hyperkalaemiaIncreased risk of mortalityAdverse cardiovascular eventsClinical epidemiological dataFollow-up lengthChronic kidney diseaseRisk of mortalityIdentified risk factorsMild hyperkalaemiaPotassium bindersRenal impairmentConcomitant medicationsHF therapyDiagnosed HFRenal functionSerum potassiumClinical careClinical outcomes
2022
Impact of Telehealth on the Current and Future Practice of Lipidology: A Scoping Review
Desai N, Marrs J, McNeal C, Mintz G, Romagnoli K, Karalis D, Jones L. Impact of Telehealth on the Current and Future Practice of Lipidology: A Scoping Review. Journal Of Clinical Lipidology 2022, 16: e36. DOI: 10.1016/j.jacl.2022.05.008.Peer-Reviewed Original ResearchLipid managementFull-text screeningTelemedicine visitsTelehealth servicesImpact of telehealthLack of reimbursementPre-post evaluationMobile health technologyLack of evidencePatient satisfactionChronic conditionsCurrent cliniciansClinical trialsLipid levelsClinician's perspectiveTelemedicine impactClinical careTelemedicine useOffice appointmentsHealth outcomesObjective/purposePubMed databaseText screeningAbstract screeningHealth system